SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-016426
Filing Date
2023-10-13
Accepted
2023-10-13 07:31:14
Documents
48
Period of Report
2023-10-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apre-20231013x8k.htm   iXBRL 8-K 39287
2 EX-99.1 apre-20231013xex99d1.htm EX-99.1 48997
3 GRAPHIC apre-20231013xex99d1g001.jpg GRAPHIC 77946
4 GRAPHIC apre-20231013xex99d1g002.jpg GRAPHIC 394277
5 GRAPHIC apre-20231013xex99d1g003.jpg GRAPHIC 154204
6 GRAPHIC apre-20231013xex99d1g004.jpg GRAPHIC 131214
7 GRAPHIC apre-20231013xex99d1g005.jpg GRAPHIC 167321
8 GRAPHIC apre-20231013xex99d1g006.jpg GRAPHIC 68182
9 GRAPHIC apre-20231013xex99d1g007.jpg GRAPHIC 72226
10 GRAPHIC apre-20231013xex99d1g008.jpg GRAPHIC 130449
11 GRAPHIC apre-20231013xex99d1g009.jpg GRAPHIC 132828
12 GRAPHIC apre-20231013xex99d1g010.jpg GRAPHIC 138152
13 GRAPHIC apre-20231013xex99d1g011.jpg GRAPHIC 138612
14 GRAPHIC apre-20231013xex99d1g012.jpg GRAPHIC 166162
15 GRAPHIC apre-20231013xex99d1g013.jpg GRAPHIC 106559
16 GRAPHIC apre-20231013xex99d1g014.jpg GRAPHIC 73284
17 GRAPHIC apre-20231013xex99d1g015.jpg GRAPHIC 153595
18 GRAPHIC apre-20231013xex99d1g016.jpg GRAPHIC 138712
19 GRAPHIC apre-20231013xex99d1g017.jpg GRAPHIC 147662
20 GRAPHIC apre-20231013xex99d1g018.jpg GRAPHIC 73318
21 GRAPHIC apre-20231013xex99d1g019.jpg GRAPHIC 171175
22 GRAPHIC apre-20231013xex99d1g020.jpg GRAPHIC 181678
23 GRAPHIC apre-20231013xex99d1g021.jpg GRAPHIC 193568
24 GRAPHIC apre-20231013xex99d1g022.jpg GRAPHIC 80214
25 GRAPHIC apre-20231013xex99d1g023.jpg GRAPHIC 144240
26 GRAPHIC apre-20231013xex99d1g024.jpg GRAPHIC 89766
27 GRAPHIC apre-20231013xex99d1g025.jpg GRAPHIC 74749
28 GRAPHIC apre-20231013xex99d1g026.jpg GRAPHIC 136963
29 GRAPHIC apre-20231013xex99d1g027.jpg GRAPHIC 150159
30 GRAPHIC apre-20231013xex99d1g028.jpg GRAPHIC 155058
31 GRAPHIC apre-20231013xex99d1g029.jpg GRAPHIC 137400
32 GRAPHIC apre-20231013xex99d1g030.jpg GRAPHIC 117857
33 GRAPHIC apre-20231013xex99d1g031.jpg GRAPHIC 116110
34 GRAPHIC apre-20231013xex99d1g032.jpg GRAPHIC 60236
35 GRAPHIC apre-20231013xex99d1g033.jpg GRAPHIC 124941
36 GRAPHIC apre-20231013xex99d1g034.jpg GRAPHIC 108501
  Complete submission text file 0001558370-23-016426.txt   6441030

Data Files

Seq Description Document Type Size
37 EX-101.SCH apre-20231013.xsd EX-101.SCH 3998
38 EX-101.DEF apre-20231013_def.xml EX-101.DEF 2847
39 EX-101.LAB apre-20231013_lab.xml EX-101.LAB 17248
40 EX-101.PRE apre-20231013_pre.xml EX-101.PRE 11358
42 EXTRACTED XBRL INSTANCE DOCUMENT apre-20231013x8k_htm.xml XML 4907
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 267-370-5219
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 231323925
SIC: 2834 Pharmaceutical Preparations